{
  "retracted": false,
  "timestamp": 1551484800000,
  "updates": [
    {
      "timestamp": 1583023226747,
      "identifier": {
        "doi": "10.1007/s10147-019-01395-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10147-018-01388-5"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration"
}
